Literature DB >> 1169906

Amikacin: a rapid and sensitive radioimmunoassay.

J E Lewis, J C Nelson, H A Elder.   

Abstract

A rapid, sensitive, and specific radioimmunoassay has been developed for the measurement of amikacin, a new semisynthetic aminoglycoside antibiotic. Antisera were produced by immunizing rabbits with amikacin conjugated to porcine thyroglobulin. Sera were screened for amikacin antibodies with (3)H-labeled amikacin. Free and bound radioactivity were separated by the second antibody method. As little as 5 ng of the antibiotic can be measured in serum, cerebrospinal fluid, and urine. The standard curve is unaffected by pH (5-11), ionic strength (0.01 M to 0.3 M), MgCl(2) or CaCl(2) (1 to 8 mM/liter), or urea (10-300 mg/100 ml). The antibodies raised to amikacin are not able to distinguish between kanamycin and amikacin. The cross reactivity of all other antibiotics tested was <0.1%. Co-incubation of first and second antibody allows for a 30-min incubation period, making the assay useful for stat determinations. The standard curve is linear on a logit-log plot, allowing for rapid computer analysis of the standard curve, interpolation of sample values, and quality-control monitoring.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1169906      PMCID: PMC429069          DOI: 10.1128/AAC.7.1.42

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  BB-K 8, a new semisynthetic aminoglycoside antibiotic.

Authors:  H Kawaguchi; T Naito; S Nakagawa; K I Fujisawa
Journal:  J Antibiot (Tokyo)       Date:  1972-12       Impact factor: 2.649

2.  One-hour radioimmunoassay of serum drug concentrations, as exemplified by digoxin and gentamicin.

Authors:  L S Berk; J L Lewis; J C Nelson
Journal:  Clin Chem       Date:  1974-09       Impact factor: 8.327

3.  Barbiturates: radioimmunoassay.

Authors:  S Spector; E J Flynn
Journal:  Science       Date:  1971-12-03       Impact factor: 47.728

4.  Radioimmunoassay of an antibiotic: gentamicin.

Authors:  J E Lewis; J C Nelson; H A Elder
Journal:  Nat New Biol       Date:  1972-10-18

5.  A radioimmunoassay for diphenylhydantoin.

Authors:  R E Tigelaar; R L Rapport; J K Inman; H J Kupferberg
Journal:  Clin Chim Acta       Date:  1973-01-24       Impact factor: 3.786

6.  Radioimmunoassay for digoxin. Technic and clinical application.

Authors:  G C Oliver; B M Parker; C W Parker
Journal:  Am J Med       Date:  1971-08       Impact factor: 4.965

7.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

8.  Morphine: radioimmunoassay.

Authors:  S Spector; C W Parker
Journal:  Science       Date:  1970-06-12       Impact factor: 47.728

9.  Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibiotics.

Authors:  K E Price; T A Pursiano; M D DeFuria
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

10.  Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans.

Authors:  B E Cabana; J G Taggart
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

View more
  11 in total

1.  Inhibition of acetylating activity in an enzymatic assay for aminoglycoside antibiotics.

Authors:  B H Minshew; S R Swanzy; F D Schoenknecht
Journal:  Antimicrob Agents Chemother       Date:  1977-11       Impact factor: 5.191

2.  Measurement of amikacin in serum by a latex agglutination inhibition test.

Authors:  R F Khabbaz; H C Standiford; D Bernstein; H C Nipper; B A Tatem; U Smalls; G L Drusano; E Caplan
Journal:  J Clin Microbiol       Date:  1985-11       Impact factor: 5.948

3.  Spectrophotometric assay for amikacin using purified kanamycin acetyltransferase.

Authors:  E Scarbrough; J W Williams; D B Northrop
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

4.  Bronchial secretion levels of amikacin.

Authors:  W L Dull; M R Alexander; J E Kasik
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

5.  Efficacy of amikacin and ceftazidime in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.

Authors:  A S Bayer; D Norman; K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

6.  Assay of gentamicin and tobramycin in sera of patients by gas-liquid chromatography.

Authors:  J W Mayhew; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

7.  Amikacin assay in serum by high-performance liquid chromatography.

Authors:  S K Maitra; T T Yoshikawa; C M Steyn; L B Guze; M C Schotz
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

8.  Substrate-labeled fluorescent immunoassay for amikacin in human serum.

Authors:  S G Thompson; J F Burd
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

9.  Intraventricular levels of amikacin after intravenous administration.

Authors:  R Yogev; W M Kolling
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

10.  Radioenzymatic assays for aminoglycosides with kanamycin 6'-acetyltransferase.

Authors:  A Weber; A L Smith; K E Opheim
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.